Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism

The American Journal of Medicine

Volumn 88, Issue 6, 1990, Pages 642-646

  Levey, Gerald S ^a   Klein, Irwin ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PROPRANOLOL; THYROID HORMONE;

ARTICLE; CARDIOVASCULAR FUNCTION; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL;

CATECHOLAMINES; HEART; HEMODYNAMICS; HUMAN; HYPERTHYROIDISM; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHOLYTICS; THYROID HORMONES;

EID: 0025368021     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90533-J     Document Type: Article

References (54)

1. New perspectives on thyroid hormone catecholamines and the heart
2. Thyroid and the heart
3. Biochemical and physiologic effects of thyroid hormone on cardiac performance
4. Thyroid-catecholamine interrelations
5. Catecholamine sensitivity, thyroid hormone and the heart
6. Adrenal medullary and thyroid relationships
7. Catecholamines and hyperthyroidism
8. The enhanced myocardial contractility of thyrotoxicosis
9. The adrenergic nervous system in hyperthyroidism: therapeutic role of beta adrenergic blocking drugs
10. Increased fat and skeletal muscle B-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis
11. Thyroid hormone and high blood pressure
12. A clinical and experimental overview of pheochromocytoma
13. Beta-adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance
14. Sympathetic nervous system blocking in hyperthyroidism
15. Influence of beta sympathetic blockade (propranolol) on the hemodynamics of hyperthyroidism
16. Adrenaline hypersensitiveness in clinical states of hyperthyroidism
17. Epinephrine its effect on the cardiac mechanism in experimental hyperthyroidism and hypothyroidism
18. Influence of thyroid state on the intrinsic contractile properties and energy stores of the myocardium
19. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats
20. Effects of thyroid hormone on the myosin content and myosin isoenzymes of the heterotopically transplanted heart
21. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms
22. Apathetic thyrotoxicosis: a distinct clinical and laboratory entity
23. Hyperthyroid heart disease
24. The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness
25. Psychiatric and neuropsychological response to propranolol in Graves' disease
26. Symptom rating scale for assessing hyperthyroidism
27. Myxedema—a study of 400 cases
28. Unusual manifestations of hypothyroidism
29. Mechanisms of action of thyroid hormones
30. Catecholamine metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism
31. Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism
32. Urinary excretion of free catecholamines in Graves' disease
33. The turnover of norepinephrine in thyrotoxic and nonthyrotoxic mice
34. Nervous system role of iodocompounds in blood pressure regulation
35. Thyroid function and high blood pressure
36. Thyroid hormone regulation of β-adrenergic number
37. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte β-adrenergic receptor density in man
38. Some aspects of the biological role of adenosine 3′5′-monophosphate
39. s in myocardial membranes from hyperthyroid pigs
40. Atrial electrophysiology in experimental hyperthyroidism in rabbits
41. Norepinephrine plasma kinetics in hypothyroid patients before and following replacement therapy
42. Factors affecting tolerance to digitalis
43. Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism
44. Therapeutic considerations
45. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis
46. Effect of adrenergic receptor blockade on the tachycardia of thyrotoxicosis and anxiety state
47. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis
48. Comparison of propranolol and metoprolol in the management of hyperthyroidism
49. Thyroid emergencies: thyroid storm and myxedema coma
50. Hyperthyroxinemia in patients treated with high-dose propranolol
51. Propranolol as primary therapy for thyrotoxicosis
52. Comparative trial of atenolol and propranolol in hyperthyroidism
53. The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients
54. Hypertension in pregnant women